Company intelligence / Profile preview

Natac Biotech

Getafe, Madrid, Spain

Ownership: Private
Development stage: Other

Overview

Natac develops and commercializes plant-based extracts and functional ingredients. Key branded products include ENDOLIVE (olive triterpenes for cardiovascular and metabolic support) and POMOLIVE (olive triterpenes combined with apple polyphenols for metabolic syndrome management). Products have demonstrated benefits including reduced inflammation, improved glycemic control, decreased blood pressure, reduced platelet aggregation, weight loss support, and improved lipid profiles.[1]

Therapeutic areas: EndocrinologyCardiovascularImmunologyMetabolic Disorders
Modalities: Plant extractFunctional ingredient
Industry: Food & Nutrition

Partnerships

Caleco Pharma Corp (exclusive license agreement for five plant extract compounds in North and South America, 2010)[2]

Beyond the preview

Go deeper on Natac Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natac Biotech.

Explore the full profile